Form 8-K - Current report:
SEC Accession No. 0001214659-21-007787
Filing Date
2021-07-23
Accepted
2021-07-23 16:30:21
Documents
3
Period of Report
2021-07-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 g7232108k.htm 8-K 17828
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 10228
3 GRAPHIC alzamendlogo_med.jpg GRAPHIC 24066
  Complete submission text file 0001214659-21-007787.txt   62461
Mailing Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612
Business Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40483 | Film No.: 211111219
SIC: 2834 Pharmaceutical Preparations